Dr Lim presented her research in a poster entitled Transforming growth factor-beta 3 in placentas and serum from patients with preeclampsia, which explored the role of proteins at cellular level in pregnant women suffering from Preeclampsia, otherwise known as hypertension in pregnancy. Until recently a Cytokine known as TGF-beta 3, a protein secreted by cells that affect cellular activity and help control inflammation, was thought to play a major role in the establishment of the placenta in early pregnancy. However, Dr Lim's research discoveries indicate that women suffering from Preeclampsia do not have significantly higher levels of TGF then healthy women. According to Dr Lim, this may reflect a relatively mild role of TGF in relation to Preeclampsia in contrast to the claims of previous research.

Preeclampsia is caused by elevated blood pressure during pregnancy and effects up to 10% of all expectant mothers. At present Preeclampsia is the leading cause of death and illness for mothers and infants and has no known cure other than an induced birth or abortion. Women who have suffered from Preeclampsia are also more likely to develop complications in the future such as liver and kidney damage as well as blood vessel diseases. For this reason, Dr Lim's research is vital in the progression towards possible treatments for this condition.
This years' conference, organised by the International Federation of Placenta Associations (IFPA), took place at Seggau Castle in Austria. The castle dates back to Roman times and served as a Bishopric for the Salzburg Archbishops from the 12th century until the 20th century when it was turned into a hotel.

The conference provided an opportunity to bring together international experts in the field of placental research. IFPA is dedicated to promoting continued development in placentology through such events that encourage the exchange of ideas and discoveries such as that of Dr Lim.